ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Brief Report
Revised

Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis

[version 4; peer review: 2 approved]
PUBLISHED 08 Jul 2022
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Pathogens gateway.

Abstract

Introduction : Bronchiolitis is the leading cause of hospitalization in children. Estimate potentially preventable variables that impact the length of hospital stay are a priority to reduce the costs associated with this disease. This study aims to identify clinical variables associated with length of hospital stay of bronchiolitis in children in a tropical middle-income country
Methods: We conducted a retrospective cohort study in 417 infants with bronchiolitis in tertiary centers in Colombia. All medical records of all patients admitted through the emergency department were reviewed. To identify factors independently associated we use negative binomial regression model, to estimate incidence rate ratios (IRR) and adjust for potential confounding variables
Results : The median of the length of hospital stay was 3.68 days, with a range of 0.74 days to 29 days, 138 (33.17%) of patients have a hospital stay of 5 or more days. After modeling and controlling for potential confounders age <6 months, comorbidities (CHD or neurological), BPD,  chest indrawing, detection of RSV, and C-reactive protein were independent predictors of LOS
Conclusions : Our results show that in infants with bronchiolitis, detection of RSV, age <6 months, comorbidities (CHD or neurological), BPD,  chest indrawing, and C-reactive protein were independent predictors of LOS. As a potentially modifiable risk factor, efforts to reduce the probability of RSV infection can reduce the high medical cost associates with prolonged LOS in bronchiolitis.

Keywords

Bronchiolitis, Colombia, respiratory syncytial virus, length of hospital stay , chest indrawing

Revised Amendments from Version 3

The term 'CRP level of more than 40 mg/lit' was clarified in the document and in the tables.There are a typo error, CRP> 40 mg/lit was considered increased. All the corrections suggested by the reviewer were modified.

See the authors' detailed response to the review by Joan L Robinson
See the authors' detailed response to the review by Mauricio T. Caballero

Introduction

Bronchiolitis is the most frequent lower respiratory tract infection in infants1,2. One of the variables with more incidence in the financial burden of this disease is the hospital length of stay (LOS)3. The hight medical cost associates with prolonged LOS in bronchiolitis imposes an economic burden, especially in tropical middle-income countries4. LOS is a direct measure of the quality of health service5.

Some models have identified predictors of LOS such as age, underlying conditions (congenital heart disease, chronic lung conditions, immunocompromised states), low birthweight, male gender, clinical characteristics at admission, prematurity, detection of RSV6. However, many of these models lack accuracy7 or were made in patients without significant comorbidities8,9. In this context, there is a critical need to explore predictors of LOS, improving their accuracy of current models. This information will allow risk management for healthcare and prioritize care strategies in groups with a high probability of prolonged hospital stay to reduce their impact on hospital costs and morbidity. This study aims to identify clinical variables associated with LOS of bronchiolitis in children in Colombia.

Methods

We conducted a retrospective cohort study that included all infants with bronchiolitis younger than two years of age admitted to tertiary centers in Rionegro, Colombia, from January 2019 to December 2019. The municipality of Rionegro had a total population of 101,046 inhabitants, with two tertiary referral hospitals10. Inclusion criteria were defined as children younger than two years of age admitted to the pediatric ward diagnosed with bronchiolitis, according to the national clinical guideline of bronchiolitis (first wheezing episode younger than 24 months of age)11. Patients without lower respiratory compromise, with positive bacterial cultures on admission, confirmed whooping cough (culture or PCR) were excluded. The study protocol was reviewed and approved by the Institutional Review Board of the University of Antioquia (No 18/2015). Informed consent was obtained from all parents or caregivers of the patients included in the study, following the clinical research standards in Colombia, and prior approval by the ethics committee.

Procedures

We collected the following variables: age, sex, weight, height, signs, and symptoms on admission (including fever, chest indrawing, chest auscultation, %SpO2), vaccination scheduled chart for age, exposure to cigarette smoking, history of prematurity and bronchopulmonary dysplasia confirmed by a neonatologist at the time of discharge from the NICU, comorbidities (congenital heart disease, neurological disease), diagnostic tools as chest X rays, hemograms, etc. Additionally, we collected variables related to outcomes of care or disease-severity parameters such as length of hospital stay. In our hospitals, bronchodilators and systemic steroids are discourage according to national clinical guidelines of bronchiolitis11. Nasopharyngeal aspirate (NPA) was taken immediately upon admission to the emergency department within 48 hrs of admission using standardize technique. RSV was confirmed using direct immunofluorescence (Light Diagnostics TM Respiratory Panel 1 DFA, Merck-Millipore Laboratory). NPA data for other viruses were not available in our institution consistently.

Statistical analysis

Continuous variables were presented as mean ± standard deviation (SD) or median (interquartile range [IQR]), whichever appropriate. Categorical variables are shown as numbers (percentage). Differences between continuous variables were analyzed using the unpaired t-test or Wilcoxon's signed-rank test, whichever was appropriate. Associations between categorical variables and the outcome variable were analyzed using the chi-square test or Fisher's exact test, as needed. To identify factors independently associated with length of hospital stay, we used a Poisson regression model, or negative binomial regression model in case of the presence of overdispersed count data, to estimate incidence rate ratios (IRR) and adjust for potential confounding variables. We only include initially variables associated with LOS with values of p <0.2 or that change the effect estimate by more than 10% after their inclusion. The variable selection and modeling processes were made following the recommendations of Greenland12. The goodness of fit of the model was evaluated using Hosmer–Lemeshow test and area under curve in Poisson regression or Akaike information criterion (AIC), Bayesian information criterion (BIC) in negative binomial regression. All statistical tests were two-tailed, and the significance level used was p < 0.05. The data were analyzed with Stata v15.0 (Stata Corporation, College Station, TX).

Results

Study population

During the study period, 417 cases of bronchiolitis were included. A total of 66% of the patient was less than 6 month, most of them males (60%), with supportive O2 (83%). RSV was detected in 200 patients (48%). Of these, 81 patients had a history of premature birth and 17 of them with BPD. A total of 20 patients had some cardiac or neurological disease and 10 of them with a history of use of palivizumab. Table 1 presents the clinical characteristics of the population. Deidentified individual-level raw data are available from Zenodo13.

Table 1. Demographic features and clinical information of the patients included in the study.

Variablen (%)
Age less than 6 month277(66.4)
Male, n(%)251(60.3)
Premature birth81(19.4)
Comorbidities (CHD or neurological)20(4.8)
BPD17(4.0)
Atopy 17(4.0)
Previously hospitalization by bronchiolitis 30(7.2)
Exposure to cigarette smoking49 (11.9)
Exclusive maternal breastfeeding for at least six month102(24.4)
%SpO2, median(ds)**89(0.2)
O2 supportive, n(%)347(83.4)
Clinical & laboratory parameters
Fever119(28.6)
Chest indrawing184(44.2)
Tachypnea48(13.3)
Rhonchi137(32.9)
Crepitation137(32.9)
Abnormal X-ray*109(26.3)
Leucocytosis (> 15.000/mm3)51(12.2)
RSV positive200(48.4)
Increased C-reactive protein (> 40 mg/lit.)327(78.6)

*Atelectasis (n=7), alveolar(n=16) or interstitial (n=48) infiltrates, hyperinflation(n=38) CHD : Congenital heart disease, BPD: Bronchopulmonary dysplasia, RSV: Respiratory syncytial virus

**value on admission without oxygen

The median of the length of hospital stay was 3.68 days, with a range of 0.74 days to 29 days and an interquartile range of 4.06 days. Among all 417 patients, 138 (33.1%) have a hospital stay of 5 or more days

Multivariate analysis of predictors associated with LOS

Unavariate analysis is presented in Table 2. Due to the significative presence of overdispersed count data was detected (Likelihood-ratio test of alpha=0, χ2= 203.97, p=0.000), a negative binomial regression model was used to adjust for potential confounding variables. The predictive variables included in the complete model were age, sex, premature birth, comorbidities, BPD, atopy, previously hospitalization by bronchiolitis, %SpO2, fever, signs of respiratory distress, RSV, Leucocytosis (>15.000/mm3) and increased C-reactive protein (>40 mg/lit.). After modeling and controlling for potential confounders in the negative binomial regression: age <6 months, comorbidities (CHD or neurological), BPD, chest indrawing, RSV isolation, and C-reactive protein were independent predictors of LOS (Table 3).

Table 2. Demographic features and clinical information of the patients included in the study.

Variable. n(%)n (%)Incidence rate-
ratio (95% CI)
p
Age less than 6 month277(66.4)0.998 (0.9-0.9)0.000
Male , n(%)251(60.3)0.048 (0.9-1.1)0.218
Premature birth81(19.4)1.319 (1.1-1.4)0.000
Comorbidities (CHD or neurological)20(4.8)1.787(1.5-2.0)0.000
BPD17(4.0)1.037(0.8-1,2)0.738
Atopy 17(4.0)0.827(0.6-1.0)0.123
Previously hospitalization by bronchiolitis 30(7.2)0.750(0.6-0.9)0.003
Exposure to cigarette smoking49 (11.9) 1.040(0.9-1.1)0.563
Exclusive maternal breastfeeding for at least six month102(24.4)0.627(0.5-1.0)0.423
SpO2, median(ds)89(0.2)1.007(0.9-1.0)0.055
O2 supportive , n(%)347(83.4)2.227(1.8-2.6)0.000
Clinical & laboratory parameters
Fever119(28.6)0.834(0.7-0.9)0.000
Chest indrawing184(44.2)1.416(1.2-1.5)0.000
Tachypnea48(13.3)1.181(1.0-1.3)0.018
Rhonchi137(32.9)0.777(0.7-0.8)0.000
Crepitation137(32.9)1.088(0.9-1.1)0.160
Abnormal X-ray*109(26.3)1.055(0.9-1.1)0.277
Leucocytosis (> 15.000/mm3)51(12.2)1.179 (1.0-1.3)0.010
RSV positive200(48.4)1.653(1.5-1.8)0.000
Increased C-reactive protein (> 40 mg/lit.)327(78.6)0.849(0.7-0.9)0.002

*Atelectasis (n=7), alveolar (n=16) or interstitial (n=48) infiltrates, hyperinflation (n=38) CHD : Congenital heart disease, BPD: Bronchopulmonary dysplasia, RSV: Respiratory syncytial virus

Table 3. Multivariate analysis of predictors associated with length of stay.

IRRCI 95%p
Age <6 months0.9980.9-0.90.000
Comorbidities (CHD or neurological)2.1191.4-3.00.000
Chest indrawing1.3221.1-1.50.001
BPD1.6101.0-2.30.017
RSV positive1.5931.3-1.80.000
Increased C-reactive protein (> 40 mg/lit.)1.0051.0-1.00.006

Discussion

The main purpose of this study was to determine the independent clinical variables associated with LOS of bronchiolitis in children in tropical middle-income countries. Our study shows that RSV, age <6 months, comorbidities (CHD or neurological), BPD, chest indrawing, and C-reactive protein were independent predictors of LOS

Our results emphasize the importance of knowing the presence of RSV. While some predictors of LOS, such as age, comorbidities, and potentially initial signs of respiratory distress, can not be modified, others as detection of RSV are potentially modifiable by interventions such as futures vaccines or palivizumab in a high-risk population14,15. Previous studies in populations with seasonality had revealed the importance of RSV as a predictor of hospital stay. DeVicenzo et al., in a sample of 141 infants <24 months old without previous chronic cardiac or lung disease or prematurity, in Tennessee described a longer LOS with a higher amount of RSV in secretions. A 1-log higher RSV load was associated with a 0.8-day longer hospitalization, reflects the higher RSV load that occur earlier in the disease14. Rodríguez-Martínez, in 303 infants with acute bronchiolitis in Bogota, also found that detection of RSV correlated with a hospital stay of 5 or more days (OR 1.92, CI 95% 1.02 to 3.73)3. In Qatar, Janahi et al., detected RSV in 51.2% of in 369 patients admitted to the pediatric ward for bronchiolitis, but no association was found between RSV and LOS16. Additionally, Masarweh et al., in a retrospective study of 4793 infants with bronchiolitis in a single tertiary medical center in Israel between 2001–2009, found that RSV isolation did not correlate with LOS17. In this evidence, only the Mansbach study used the PCR assay for viral detection, but the results with immunofluorescence assay with respect to the predictive value of RSV were similar to the PCR assay. Indeed, the main problem of the studies mentioned above was the serious statistical mistakes of analyzing the LOS. While we used a negative binomial regression model, due to the presence of overdispersed count data, to adjust for potential confounding variables to analyze LOS, studies by Rodriguez, Devicenzo, and Mansbach dichotomize the LOS to perform logistic regression, while Masarweh's study performed a linear regression; being both approaches not completely correct. The loss of information from dichotomizing a continuous outcome is well documented in the literature, and even worse, analyzing a variable that does not have a normal distribution with a linear regression invalidates this method of analysis18. These pitfalls in statistical analysis can explain the lack of accuracy of predictive models6. The regression models recommended are median, gamma, or Poisson regression, which have some type I error but avoid the mistakes previously mentioned with the logistic or linear regression model.

Othe variable potentially modifiable associated with LOS was age <6 months. Our findings are consistent with previous results reported in the literature and provide further evidence that younger infants are at a greater risk of requiring prolonged LOS3. This can be explained because the smaller caliber of the airways in younger infants and poor innate immune response to RSV in newborns, making younger infants more susceptible to severe forms of viral infections and prolonged LOS19,20. Preventive strategies such as the use of palivizumab in a high-risk population or the use of future vaccines that confer immunity in children under 6 months against RSV; will constitute possibly effective interventions in reducing the economic burden of this disease.

Several predictive models had reports consistently the chest indrawing as predictive of prolonged LOS that is which is biologically plausible and expected due that this sign also is a universal marker of severity of the disease, as well as the presence of underlying conditions (congenital heart disease, chronic lung conditions, immunocompromised states)3,68,2123 or C-reactive protein (CRP) as a biomarker of severity and bacterial co-infection in patients hospitalized for bronchiolitis2426

Our study has limitations. First, since this study was based on medical records review, we cannot include other variables such as environmental pollution and genetic factors, and residual confounding cannot be excluded. Second, respiratory syncytial virus was confirmed using direct immunofluorescence, which may underestimate the real burden of viral infection. However, despite this possible underestimation, RSV infection was positively associated, and it is possible that the magnitude of the IRR is even greater. The detection of other respiratory viruses was not homogeneous in all patients, so to avoid information bias we decided not to include them in the analysis. We cannot rule out that other respiratory viruses have equal or greater association with our dependent variable in the study. Third, the study was conducted in a tertiary referral hospital, and therefore the patients included represent the high spectrum of severity, limiting the generalization of results to other contexts. However, the similarity of our population in terms of clinical characteristics, risk factors, and seasonality of bronchiolitis in our country with previous reports suggest strength and consistency in our results3,4

Conclusion

Our results show that in infants with bronchiolitis, RSV, age <6 months, comorbidities (CHD or neurological), BPD, chest indrawing, and C-reactive protein were independent predictors of LOS in a tropical middle-income country. As a potentially modifiable risk factor, efforts to reduce the probability of RSV infection can reduce the hight medical cost associates with prolonged LOS in bronchiolitis.

Data availability

Underlying data

Zenodo: Importance of respiratory syncytial virus as a predictor of hospital length of stay in Bronchiolitis. http://doi.org/10.5281/zenodo.443243413.

This project contains the raw data for each patient assessed in the present study.

Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).

Declarations

Ethics approval

The study protocol was reviewed and approved by the Institutional Review Board of Clinica Somer (No 281015) and the University of Antioquia (No 18/2015).

Consent for publication

All authors consent this paper for publication

Abbreviations

incidence rate ratios (IRR)

hospital length of stay (LOS)

respiratory syncytial virus (RSV)

Nasopharyngeal aspirate (NPA

Bronchopulmonary dysplasia (BPD)

Chronic heart disease (CHD)

Comments on this article Comments (0)

Version 4
VERSION 4 PUBLISHED 15 Feb 2021
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Buendia JA and Guerrero Patino D. Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis [version 4; peer review: 2 approved]. F1000Research 2022, 10:110 (https://doi.org/10.12688/f1000research.40670.4)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 4
VERSION 4
PUBLISHED 08 Jul 2022
Revised
Views
7
Cite
Reviewer Report 12 Jul 2022
Joan L Robinson, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada 
Approved
VIEWS 7
One residual problem is that it is ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Robinson JL. Reviewer Report For: Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis [version 4; peer review: 2 approved]. F1000Research 2022, 10:110 (https://doi.org/10.5256/f1000research.135025.r143683)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 3
VERSION 3
PUBLISHED 20 Dec 2021
Revised
Views
20
Cite
Reviewer Report 24 Dec 2021
Joan L Robinson, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada 
Approved with Reservations
VIEWS 20
I am not very happy with the response to my review. The authors simply put the word "corrected" after each of my comments even though some of the comments were not addressed. For example, the discussion still talks about HSV. The ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Robinson JL. Reviewer Report For: Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis [version 4; peer review: 2 approved]. F1000Research 2022, 10:110 (https://doi.org/10.5256/f1000research.81423.r116157)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 06 Jan 2022
    Jefferson Buendia, Pharmacology and Toxicology Department, Pharmacology and Toxicology Research Group, Faculty of Medicine, Universidad de Antioquia., Medellín, 053212, Colombia
    06 Jan 2022
    Author Response
    Dear reviewer.
    You can see that all grammar suggestions were corrected according to your advice. 
    When we place in our corrections the word "corrected" it means that the text was ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 06 Jan 2022
    Jefferson Buendia, Pharmacology and Toxicology Department, Pharmacology and Toxicology Research Group, Faculty of Medicine, Universidad de Antioquia., Medellín, 053212, Colombia
    06 Jan 2022
    Author Response
    Dear reviewer.
    You can see that all grammar suggestions were corrected according to your advice. 
    When we place in our corrections the word "corrected" it means that the text was ... Continue reading
Version 2
VERSION 2
PUBLISHED 02 Jul 2021
Revised
Views
17
Cite
Reviewer Report 29 Nov 2021
Joan L Robinson, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada 
Approved with Reservations
VIEWS 17
The authors analyzed data from all children less than 2 years of age admitted in 2019 to two hospitals in Columbia to establish factors identifiable at admission that predict a longer length of stay (LOS). The factors that they identified ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Robinson JL. Reviewer Report For: Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis [version 4; peer review: 2 approved]. F1000Research 2022, 10:110 (https://doi.org/10.5256/f1000research.58307.r99869)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 20 Dec 2021
    Jefferson Buendia, Pharmacology and Toxicology Department, Pharmacology and Toxicology Research Group, Faculty of Medicine, Universidad de Antioquia., Medellín, 053212, Colombia
    20 Dec 2021
    Author Response
    Response : Reviewer 2
    • The authors analyzed data from all children less than 2 years of age admitted in 2019 to two hospitals in Columbia to establish factors
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 20 Dec 2021
    Jefferson Buendia, Pharmacology and Toxicology Department, Pharmacology and Toxicology Research Group, Faculty of Medicine, Universidad de Antioquia., Medellín, 053212, Colombia
    20 Dec 2021
    Author Response
    Response : Reviewer 2
    • The authors analyzed data from all children less than 2 years of age admitted in 2019 to two hospitals in Columbia to establish factors
    ... Continue reading
Views
9
Cite
Reviewer Report 12 Nov 2021
Mauricio T. Caballero, INFANT Foundation, Buenos Aires, Argentina 
Approved
VIEWS 9
The authors have ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Caballero MT. Reviewer Report For: Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis [version 4; peer review: 2 approved]. F1000Research 2022, 10:110 (https://doi.org/10.5256/f1000research.58307.r88922)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 15 Feb 2021
Views
23
Cite
Reviewer Report 28 Jun 2021
Mauricio T. Caballero, INFANT Foundation, Buenos Aires, Argentina 
Approved with Reservations
VIEWS 23
Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis is an interesting retrospective study conducted in tertiary centers in Rionegro, Colombia, from January 2019 to December 2019. The study explores variables associated with length of stay ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Caballero MT. Reviewer Report For: Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis [version 4; peer review: 2 approved]. F1000Research 2022, 10:110 (https://doi.org/10.5256/f1000research.43735.r85075)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 20 Dec 2021
    Jefferson Buendia, Pharmacology and Toxicology Department, Pharmacology and Toxicology Research Group, Faculty of Medicine, Universidad de Antioquia., Medellín, 053212, Colombia
    20 Dec 2021
    Author Response
    We appreciate your valuable comments. 
    • Respiratory syncytial virus was confirmed using direct immunofluorescence, which may underestimate the real burden of viral infection. How do authors estimate this could
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 20 Dec 2021
    Jefferson Buendia, Pharmacology and Toxicology Department, Pharmacology and Toxicology Research Group, Faculty of Medicine, Universidad de Antioquia., Medellín, 053212, Colombia
    20 Dec 2021
    Author Response
    We appreciate your valuable comments. 
    • Respiratory syncytial virus was confirmed using direct immunofluorescence, which may underestimate the real burden of viral infection. How do authors estimate this could
    ... Continue reading

Comments on this article Comments (0)

Version 4
VERSION 4 PUBLISHED 15 Feb 2021
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.